Cirrhosis in over 16s: assessment and management.

  • Guideline Summary
  • NGC:009796
  • 1998 Jan (revised 2013 Feb)

Management of adult patients with ascites due to cirrhosis: update 2012.

  • Guideline Summary
  • NGC:010545
  • 2012 Aug

SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver.

  • Guideline Summary
  • NGC:011021
  • 2016 Jul 6

Non-alcoholic fatty liver disease (NAFLD): assessment and management.

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection.

  • Guideline Summary
  • NGC:010213
  • 2008 Jun (revised 2014)

Esophageal varices.

  • Guideline Summary
  • NGC:010903
  • 2016 Jan

AASLD guidelines for treatment of chronic hepatitis B.

  • Guideline Summary
  • NGC:009204
  • 2012 Jun

NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents.

  • Guideline Summary
  • NGC:009150
  • 2002 (revised 2012 Jun)

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

  • Guideline Summary
  • NGC:009890
  • 2013 Jan

Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

  • Guideline Summary
  • NGC:010448
  • 1998 (revised 2014)

ACR Appropriateness Criteria® liver lesion — initial characterization.

British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.

VA/DoD clinical practice guideline for the management of substance use disorders.

Hepatitis B virus.

Management of hepatitis C. A national clinical guideline.

  • Guideline Summary
  • NGC:009937
  • 2004 Mar 16 (revised 2013 Sep 3)

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:009072
  • 2012 Apr

Boceprevir for the treatment of genotype 1 chronic hepatitis C.